As of 2026-10-16, the Relative Valuation of Oramed Pharmaceuticals Inc (ORMP) is 59.62 USD. This relative valuation is based on P/E multiples. With the latest stock price at 4.18 USD, the upside of Oramed Pharmaceuticals Inc based on Relative Valuation is 1326.4%.
The range of the Relative Valuation is 22.55 - 140.48 USD.
| Range | Selected | |
| Trailing P/E multiples | 13.0x - 32.9x | 21.2x |
| Forward P/E multiples | 13.7x - 21.5x | 17.5x |
| Fair Price | 22.55 - 140.48 | 59.62 |
| Upside | 439.4% - 3260.7% | 1326.4% |
| Date | P/E |
| 2026-10-15 | 0.98 |
| 2026-10-14 | 0.97 |
| 2026-10-13 | 0.98 |
| 2026-10-12 | 1.00 |
| 2026-10-09 | 1.01 |
| 2026-10-08 | 0.98 |
| 2026-10-07 | 1.02 |
| 2026-10-06 | 1.03 |
| 2026-10-05 | 1.06 |
| 2026-10-02 | 1.05 |
| 2026-10-01 | 1.05 |
| 2026-09-30 | 1.09 |
| 2026-09-29 | 1.10 |
| 2026-09-28 | 1.11 |
| 2026-09-25 | 1.11 |
| 2026-09-24 | 1.12 |
| 2026-09-23 | 1.10 |
| 2026-09-22 | 1.11 |
| 2026-09-21 | 1.10 |
| 2026-09-18 | 1.11 |
| 2026-09-17 | 1.09 |
| 2026-09-16 | 1.08 |
| 2026-09-15 | 1.08 |
| 2026-09-14 | 1.09 |
| 2026-09-11 | 1.09 |
| 2026-09-10 | 1.11 |
| 2026-09-09 | 1.12 |
| 2026-09-08 | 1.17 |
| 2026-09-04 | 1.17 |
| 2026-09-03 | 1.15 |
| 2026-09-02 | 1.19 |
| 2026-09-01 | 1.14 |
| 2026-08-31 | 1.17 |
| 2026-08-28 | 1.18 |
| 2026-08-27 | 1.19 |
| 2026-08-26 | 1.25 |
| 2026-08-25 | 1.22 |
| 2026-08-24 | 1.13 |
| 2026-08-21 | 1.13 |
| 2026-08-20 | 1.12 |
| 2026-08-19 | 1.12 |
| 2026-08-18 | 1.12 |
| 2026-08-17 | 1.07 |
| 2026-08-14 | 1.05 |
| 2026-08-13 | 1.03 |
| 2026-08-12 | 1.00 |
| 2026-08-11 | 0.99 |
| 2026-08-10 | 0.98 |
| 2026-08-07 | 1.01 |
| 2026-08-06 | 1.01 |